LENVATOL 4 Mg (LENVATINIB 4 MG)

LENVATOL 4 mg is a targeted therapy medicine containing Lenvatinib, used for treating thyroid, kidney, and liver cancers. Oral tablet for advanced cancer care.

PACK SIZE Price Add to Cart
30 Capsules - USD $3.33 / Capsule$100.00
View Cart
60 Capsules - USD $3.25 / Capsule$195.00
View Cart
90 Capsules - USD $3.11/ Capsule$280.00
View Cart

LENVATOL 4 Mg (LENVATINIB 4 MG)

Active IngredientLenvatinib
ManufacturersCipla Limited
IndicationsThyroid cancer
Strength4mg
Packaging10 Tablets in 1 Strip
Delivery Time6 To 15 days

LENVATOL 4 mg contains Lenvatinib, a targeted cancer treatment used for patients with advanced or metastatic thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer). As a tyrosine kinase inhibitor (TKI), Lenvatinib blocks the growth signals cancer cells need to multiply, helping to shrink tumors and slow disease progression.

LENVATOL 4 mg is often prescribed either alone or in combination with other therapies, depending on the type and stage of cancer. Taken orally once daily, it should always be used under strict oncologist supervision, as dosage and duration vary per individual.

Important: Close monitoring of liver function, blood pressure, and side effects is necessary during treatment.

PACK SIZE

30 Capsules – USD $3.33 / Capsule, 60 Capsules – USD $3.25 / Capsule, 90 Capsules – USD $3.11/ Capsule

There are no reviews yet.

Be the first to review “LENVATOL 4 Mg (LENVATINIB 4 MG)”